Trial Profile
Phase 1, Open-Label, Fed, Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of XP13512 Extended Release (ER) Tablets Co Administered with Cimetidine (Tagamet®) in Healthy Adult Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs Gabapentin enacarbil (Primary) ; Cimetidine
- Indications Diabetic neuropathies; Postherpetic neuralgia; Restless legs syndrome
- Focus Pharmacokinetics
- 18 Oct 2013 New trial record